SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5gl7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EKJ_B_CUB4_0
(BETA-CARBONIC
ANHYDRASE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 CYH A 438
CYH A 389
PRO A 442
SER A 440
ZN  A 901 (-2.5A)
ZN  A 901 (-2.1A)
None
ZN  A 901 ( 4.0A)
1.31A 1ekjA-5gl7A:
1.4
1ekjB-5gl7A:
1.5
1ekjA-5gl7A:
15.85
1ekjB-5gl7A:
15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MT1_A_AG2A7005_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 LEU A 681
ASP A 678
LEU A 674
ARG A 737
None
0.78A 1mt1A-5gl7A:
undetectable
1mt1F-5gl7A:
undetectable
1mt1A-5gl7A:
8.70
1mt1F-5gl7A:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MT1_B_AG2B7001_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 ARG A 737
LEU A 681
ASP A 678
LEU A 674
None
0.79A 1mt1B-5gl7A:
undetectable
1mt1C-5gl7A:
undetectable
1mt1B-5gl7A:
11.48
1mt1C-5gl7A:
8.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MT1_G_AG2G7003_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 LEU A 681
ASP A 678
LEU A 674
ARG A 737
None
0.81A 1mt1G-5gl7A:
undetectable
1mt1J-5gl7A:
undetectable
1mt1G-5gl7A:
8.70
1mt1J-5gl7A:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N13_B_AG2B7011_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 5 ARG A 737
LEU A 681
ASP A 678
LEU A 674
None
0.80A 1n13B-5gl7A:
undetectable
1n13C-5gl7A:
undetectable
1n13B-5gl7A:
11.48
1n13C-5gl7A:
8.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N13_H_AG2H7012_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 ARG A 737
LEU A 681
ASP A 678
LEU A 674
None
0.84A 1n13H-5gl7A:
undetectable
1n13K-5gl7A:
undetectable
1n13H-5gl7A:
11.48
1n13K-5gl7A:
8.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N13_J_AG2J7013_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 LEU A 681
ASP A 678
LEU A 674
ARG A 737
None
0.83A 1n13G-5gl7A:
undetectable
1n13J-5gl7A:
undetectable
1n13G-5gl7A:
8.70
1n13J-5gl7A:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N13_L_AG2L7014_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 LEU A 681
ASP A 678
LEU A 674
ARG A 737
None
0.83A 1n13I-5gl7A:
undetectable
1n13L-5gl7A:
undetectable
1n13I-5gl7A:
8.70
1n13L-5gl7A:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V8B_C_ADNC2502_1
(ADENOSYLHOMOCYSTEINA
SE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 12 GLU A 402
ASP A 416
ASP A 419
LEU A 430
GLY A 403
None
1.44A 1v8bC-5gl7A:
3.1
1v8bC-5gl7A:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DG9_A_RAPA501_1
(FK506-BINDING
PROTEIN 1A)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 ASP A 605
ILE A 284
LEU A 281
HIS A 340
ILE A 339
None
1.17A 2dg9A-5gl7A:
undetectable
2dg9A-5gl7A:
13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EJF_B_ADNB2002_1
(235AA LONG
HYPOTHETICAL
BIOTIN--[ACETYL-COA-
CARBOXYLASE] LIGASE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 ARG A 394
ASN A 276
PRO A 329
ALA A 322
None
1.32A 2ejfB-5gl7A:
undetectable
2ejfB-5gl7A:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EJG_A_ADNA1501_1
(235AA LONG
HYPOTHETICAL
BIOTIN--[ACETYL-COA-
CARBOXYLASE] LIGASE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 ARG A 394
ASN A 276
PRO A 329
ALA A 322
None
1.29A 2ejgA-5gl7A:
undetectable
2ejgA-5gl7A:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_A_AG2A671_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 ARG A 737
LEU A 681
ASP A 678
LEU A 674
None
0.79A 2qqcB-5gl7A:
undetectable
2qqcC-5gl7A:
undetectable
2qqcB-5gl7A:
11.31
2qqcC-5gl7A:
8.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_A_AG2A672_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 LEU A 681
ASP A 678
LEU A 674
ARG A 737
None
0.80A 2qqcA-5gl7A:
undetectable
2qqcF-5gl7A:
undetectable
2qqcA-5gl7A:
8.50
2qqcF-5gl7A:
11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_I_AG2I671_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 LEU A 681
ASP A 678
LEU A 674
ARG A 737
None
0.78A 2qqcG-5gl7A:
undetectable
2qqcJ-5gl7A:
undetectable
2qqcG-5gl7A:
8.50
2qqcJ-5gl7A:
11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_I_AG2I672_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 LEU A 681
ASP A 678
LEU A 674
ARG A 737
None
0.78A 2qqcI-5gl7A:
undetectable
2qqcL-5gl7A:
undetectable
2qqcI-5gl7A:
8.50
2qqcL-5gl7A:
11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQD_A_AG2A671_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 LEU A 681
ASP A 678
LEU A 674
ARG A 737
None
0.82A 2qqdA-5gl7A:
undetectable
2qqdE-5gl7A:
undetectable
2qqdA-5gl7A:
8.50
2qqdE-5gl7A:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2RLF_A_RIMA199_1
(MATRIX PROTEIN 2)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 LEU A 622
LEU A 621
ILE A 701
ARG A 702
None
0.95A 2rlfA-5gl7A:
undetectable
2rlfB-5gl7A:
undetectable
2rlfA-5gl7A:
5.12
2rlfB-5gl7A:
5.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2RLF_C_RIMC399_1
(MATRIX PROTEIN 2)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 LEU A 622
LEU A 621
ILE A 701
ARG A 702
None
1.01A 2rlfC-5gl7A:
undetectable
2rlfD-5gl7A:
undetectable
2rlfC-5gl7A:
5.12
2rlfD-5gl7A:
5.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZM8_A_ACAA511_1
(6-AMINOHEXANOATE-DIM
ER HYDROLASE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 8 ALA A 291
ILE A 349
TYR A 344
HIS A 340
None
0.93A 2zm8A-5gl7A:
undetectable
2zm8A-5gl7A:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZMA_A_ACAA501_1
(6-AMINOHEXANOATE-DIM
ER HYDROLASE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 8 ALA A 291
ILE A 349
TYR A 344
HIS A 340
None
0.93A 2zmaA-5gl7A:
undetectable
2zmaA-5gl7A:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CE6_B_ADNB500_2
(ADENOSYLHOMOCYSTEINA
SE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 5 LEU A 499
THR A 316
THR A 496
HIS A 449
None
1.22A 3ce6B-5gl7A:
3.0
3ce6B-5gl7A:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_H_SAMH300_0
(PUTATIVE RRNA
METHYLASE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 12 ASN A 542
ILE A 528
GLY A 524
LEU A 306
THR A 269
None
1.07A 3eeyH-5gl7A:
2.3
3eeyH-5gl7A:
16.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OZU_A_X89A411_1
(FLAVOHEMOPROTEIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 12 ILE A 708
TYR A 692
LEU A 756
VAL A 763
ALA A 614
None
1.29A 3ozuA-5gl7A:
2.6
3ozuA-5gl7A:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3Q70_A_RITA2001_2
(CANDIDAPEPSIN-2)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 ILE A 343
TYR A 344
ASP A 312
THR A 269
None
1.00A 3q70A-5gl7A:
undetectable
3q70A-5gl7A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SUD_A_SUEA1201_2
(NS3 PROTEASE, NS4A
PROTEIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 4 PHE A 551
TYR A 297
ILE A 624
LEU A 621
None
1.32A 3sudA-5gl7A:
undetectable
3sudA-5gl7A:
15.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SUE_C_SUEC1201_2
(NS3 PROTEASE, NS4A
PROTEIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 5 PHE A 551
TYR A 297
ILE A 624
LEU A 621
None
1.28A 3sueC-5gl7A:
undetectable
3sueC-5gl7A:
15.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WG7_B_CHDB303_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.42A 3wg7A-5gl7A:
1.6
3wg7B-5gl7A:
undetectable
3wg7T-5gl7A:
undetectable
3wg7A-5gl7A:
20.77
3wg7B-5gl7A:
16.40
3wg7T-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A79_A_P1BA601_1
(AMINE OXIDASE
[FLAVIN-CONTAINING]
B)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 12 PRO A 758
LEU A 696
LEU A 689
ILE A 708
PHE A 785
None
1.24A 4a79A-5gl7A:
undetectable
4a79A-5gl7A:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BQT_C_C5EC301_0
(SOLUBLE
ACETYLCHOLINE
RECEPTOR)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 8 TYR A 759
VAL A 699
TYR A 692
TYR A 297
None
1.31A 4bqtC-5gl7A:
undetectable
4bqtD-5gl7A:
undetectable
4bqtC-5gl7A:
17.03
4bqtD-5gl7A:
17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4COX_A_IMNA701_1
(CYCLOOXYGENASE-2)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 12 VAL A 293
LEU A 695
TYR A 692
VAL A 699
LEU A 622
None
1.14A 4coxA-5gl7A:
undetectable
4coxA-5gl7A:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4COX_B_IMNB701_1
(CYCLOOXYGENASE-2)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 12 VAL A 293
LEU A 695
TYR A 692
VAL A 699
LEU A 622
None
1.15A 4coxB-5gl7A:
undetectable
4coxB-5gl7A:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4COX_D_IMND701_1
(CYCLOOXYGENASE-2)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 12 VAL A 293
LEU A 695
TYR A 692
VAL A 699
LEU A 622
None
1.15A 4coxD-5gl7A:
undetectable
4coxD-5gl7A:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 THR A 366
ALA A 521
THR A 522
THR A 357
None
1.01A 4qw0K-5gl7A:
undetectable
4qw0K-5gl7A:
17.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 7 THR A 366
ALA A 521
THR A 522
THR A 357
None
1.01A 4qw0Y-5gl7A:
undetectable
4qw0Y-5gl7A:
17.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWP_B_GCSB302_1
(CHITOSANASE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 5 GLU A 313
TYR A 274
ILE A 332
THR A 318
None
1.32A 4qwpB-5gl7A:
undetectable
4qwpB-5gl7A:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X20_D_LOCD502_2
(TUBULIN BETA CHAIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 LEU A 786
LEU A 689
LEU A 782
VAL A 754
ILE A 780
None
1.05A 4x20D-5gl7A:
undetectable
4x20D-5gl7A:
20.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XI3_B_29SB601_1
(ESTROGEN RECEPTOR)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 12 ALA A 291
LEU A 289
ARG A 299
ILE A 528
GLY A 310
None
0.99A 4xi3B-5gl7A:
undetectable
4xi3B-5gl7A:
17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B1A_B_CHDB303_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.44A 5b1aA-5gl7A:
1.6
5b1aB-5gl7A:
undetectable
5b1aT-5gl7A:
undetectable
5b1aA-5gl7A:
20.77
5b1aB-5gl7A:
16.40
5b1aT-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B1B_B_CHDB303_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.45A 5b1bA-5gl7A:
1.9
5b1bB-5gl7A:
undetectable
5b1bT-5gl7A:
undetectable
5b1bA-5gl7A:
20.77
5b1bB-5gl7A:
16.40
5b1bT-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B3S_B_CHDB304_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.46A 5b3sA-5gl7A:
1.3
5b3sB-5gl7A:
undetectable
5b3sT-5gl7A:
undetectable
5b3sA-5gl7A:
20.77
5b3sB-5gl7A:
16.40
5b3sT-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HRQ_G_IPHG101_0
(INSULIN A-CHAIN
INSULIN B-CHAIN)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 HIS A 793
LEU A 773
CYH A 787
LEU A 244
None
1.50A 5hrqD-5gl7A:
undetectable
5hrqG-5gl7A:
undetectable
5hrqH-5gl7A:
undetectable
5hrqD-5gl7A:
3.79
5hrqG-5gl7A:
4.15
5hrqH-5gl7A:
3.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIX_B_OQRB302_0
(SULFOTRANSFERASE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 10 PRO A 433
ILE A 425
VAL A 401
LEU A 396
ASP A 416
None
1.40A 5tixB-5gl7A:
undetectable
5tixB-5gl7A:
17.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X19_B_CHDB302_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.47A 5x19A-5gl7A:
1.7
5x19B-5gl7A:
undetectable
5x19T-5gl7A:
undetectable
5x19A-5gl7A:
20.77
5x19B-5gl7A:
16.40
5x19T-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDQ_B_CHDB304_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.47A 5xdqA-5gl7A:
0.2
5xdqB-5gl7A:
undetectable
5xdqT-5gl7A:
undetectable
5xdqA-5gl7A:
20.77
5xdqB-5gl7A:
16.40
5xdqT-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y9A_A_AR3A201_1
(PEPTIDYL-TRNA
HYDROLASE)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
4 / 6 ALA A 571
GLN A 372
LYS A 375
GLN A 371
None
1.16A 5y9aA-5gl7A:
2.5
5y9aA-5gl7A:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z84_B_CHDB301_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.45A 5z84A-5gl7A:
1.4
5z84B-5gl7A:
undetectable
5z84T-5gl7A:
undetectable
5z84A-5gl7A:
20.77
5z84B-5gl7A:
16.40
5z84T-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z86_B_CHDB302_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.46A 5z86A-5gl7A:
1.6
5z86B-5gl7A:
undetectable
5z86T-5gl7A:
undetectable
5z86A-5gl7A:
20.77
5z86B-5gl7A:
16.40
5z86T-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCO_B_CHDB302_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.43A 5zcoA-5gl7A:
0.2
5zcoB-5gl7A:
undetectable
5zcoT-5gl7A:
undetectable
5zcoA-5gl7A:
20.77
5zcoB-5gl7A:
16.40
5zcoT-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCP_B_CHDB301_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.46A 5zcpA-5gl7A:
0.2
5zcpB-5gl7A:
undetectable
5zcpT-5gl7A:
undetectable
5zcpA-5gl7A:
20.77
5zcpB-5gl7A:
16.40
5zcpT-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCQ_B_CHDB301_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 11 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.45A 5zcqA-5gl7A:
0.2
5zcqB-5gl7A:
undetectable
5zcqT-5gl7A:
undetectable
5zcqA-5gl7A:
20.77
5zcqB-5gl7A:
16.40
5zcqT-5gl7A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B58_A_ACTA608_0
(FUMARATE REDUCTASE
FLAVOPROTEIN SUBUNIT)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
3 / 3 GLY A 355
THR A 311
GLU A 313
None
0.57A 6b58A-5gl7A:
5.3
6b58A-5gl7A:
23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BZO_C_FI8C1201_0
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 12 THR A 359
GLN A 362
THR A 503
VAL A 514
VAL A 505
None
1.35A 6bzoC-5gl7A:
undetectable
6bzoC-5gl7A:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6E5Z_A_CCSA106_0
(PROTEIN/NUCLEIC ACID
DEGLYCASE DJ-1)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 10 GLY A 667
GLY A 666
ILE A 795
THR A 797
GLY A 658
None
1.02A 6e5zA-5gl7A:
undetectable
6e5zA-5gl7A:
16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NMP_B_CHDB303_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC

(Homo
sapiens)
5 / 9 MET A 659
GLY A 658
GLN A 770
THR A 766
GLY A 651
None
1.46A 6nmpA-5gl7A:
0.6
6nmpB-5gl7A:
0.0
6nmpT-5gl7A:
0.0
6nmpA-5gl7A:
20.77
6nmpB-5gl7A:
16.40
6nmpT-5gl7A:
8.85